Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2006-06-23Clinical Trial Update: Short-Term Effects of Medicinal Cannabis Therapy on Spasticity in Multiple Sclerosis [Phase 1, Phase 2]
This update summarizes the short-term effects of medicinal cannabis therapy on spasticity in people with multiple sclerosis from a Phase 1/2…
-
CLINICAL_TRIALS trial_result · 2006-06-20Clinical Trial Update: Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) Kit [Phase 2]
This Phase 2 clinical trial update investigates whether a short training period with an APOS kit improves balance in people with multiple sc…
-
FDA approval · 2006-06-05FDA Approved: TYSABRI — Supplemental Application (Biogen Inc.)
The FDA approved Biogen's supplemental application for TYSABRI (natalizumab), resulting in an approved change to the product's labeling/auth…
-
CLINICAL_TRIALS trial_result · 2006-06-05Clinical Trial Update: Optic Neuritis Treatment Trial (ONTT) [Phase 3]
Clinical trial update for the Optic Neuritis Treatment Trial (ONTT), a Phase 3 NEI-sponsored study comparing high-dose intravenous methylpre…
-
CLINICAL_TRIALS research · 2006-05-29Clinical Trial Update: Longitudinal Optic Neuritis Study (LONS) [NA]
This is a clinical trial update for the Longitudinal Optic Neuritis Study (LONS) sponsored by the National Eye Institute. The current status…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.